Moderna

moderna, the second Covid vaccine to be granted emergency use authorization in the United States, will make inroads in India next year.

The lawsuit, which seeks undetermined monetary damages, was being filed in US District Court in Massachusetts and the Regional Court of Dusseldorf in Germany, moderna said in a news release on Friday.

moderna on Wednesday said its flu vaccine had generated a stronger immune response against all four A and B strains of the influenza virus compared to traditional flu shots in a late-stage trial. The effectiveness of moderna's flu vaccine was demonstrated across all age groups, and was found to be safe and tolerable, according to the company. moderna also said it had found that its shot was equal or superior to Sanofi's high-dose flu vaccine in a separate early head-to-head study.

The US Food and Drug Administration on Tuesday issued a positively-worded briefing document about the moderna Covid-19 vaccine ahead of a meeting by experts on whether to grant it emergency approval. The FDA was upbeat on the vaccine, saying there were no specific safety concerns identified that would require EUA and the confirmed an overall efficacy of 94.1%.

"We are very pleased that our Covid-19 vaccine efficacy is stable at 93% from four to six months," moderna chief executive Stéphane Bancel said in a statement. "This strong duration will benefit the hundreds of millions of people who have been dosed to date with moderna vaccines."

moderna is gearing up to halve the dose of its Covid-19 vaccine so that it can also be used to combat variants and inoculate children. It has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen, Netherlands, will have capacity to make ingredients for up to 300 million doses annually at 50 micrograms per dose.

New data from moderna Inc's large Covid-19 vaccine trial shows that the protection it offers declines over time, supporting the case for booster doses, the company said in a news release on Wednesday. Several recent studies have suggested that its vaccine may have an edge over a similar shot from Pfizer Inc and German partner BioNTech SE in terms of maintaining efficacy over time

moderna Inc will apply for US and European emergency authorization for its Covid-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns. moderna also reported that its vaccine's efficacy rate was consistent across age, race, ethnicity and gender demographics.

moderna has long been a darling of investors but it wasn't until the coronavirus pandemic came along that the biotech company could prove the value of its new vaccine technology and mint some new billionaires. moderna announced on Monday that its experimental Covid-19 vaccine was 94.5% effective, about the same efficacy as the common vaccine against measles.

Britain's medical regulator on Friday approved moderna's Covid-19 vaccine for use, the health ministry said, adding that it had agreed to purchase an additional 10 million doses of the shot as it eyed a spring rollout of the shot.

moderna Inc said on Wednesday its Covid-19 vaccine booster targeting the BA.1 subvariant of Omicron generated a strong immune response against that variant, with antibody levels staying high for at least three months. The United States has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron.

India’s top drug company, Cipla will "facilitate" the import of Covid vaccines donated by US biotech major moderna into the country through the licence by the drugs regulator.

moderna Inc. has filed a request with the European Medicines Agency for its Covid-19 vaccine to be granted authorization for use in adolescents.

London's High Court invalidated one of moderna's COVID-19 vaccine technology patents, upheld another infringed by Pfizer and BioNTech's Comirnaty vaccine. Global legal battles continue as companies plan to appeal, ensuring vaccine production remains unaffected.

Seeking fast-track approvals to bring moderna's single-dose Covid-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that it is close to committing over $1 billion as advance to the US major, sources said on Monday.

moderna was the first to start human testing of a vaccine for the novel coronavirus on March 16, 66 days after the genetic sequence of the virus was released.

moderna Inc believed from the beginning of the Covid-19 pandemic that BioNTech SE used its intellectual property in producing a rival vaccine, Chief Executive Stephane Bancel said on Wednesday.

moderna Inc said on Saturday the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted to recommend the use of the company's Covid-19 vaccine on people 18 years of age and older. moderna's is the second Covid-19 vaccine to receive approval in the US. US distribution of moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.

moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the US Food and Drug Administration, welcome news to a nation with a staggering Covid-19 death toll of over 307,000 lives lost.

Having received emergency use authorisation, US-based biotechnology major moderna is all set to bring in the country's first mRNA vaccine

Vaccine manufacturer moderna has refused to send vaccines directly to the Punjab government, reported news agency ANI. moderna said it only deals with the government of India and not with any state government or any private party, said Punjab's nodal officer for vaccination. So far, about 90 million people have been inoculated with moderna's COVID-19 vaccine globally.

moderna Inc said on Wednesday it expects that the immunity induced by its Covid-19 vaccine would be protective against the coronavirus variants reported in the UK. moderna plans to run tests to confirm the vaccine's activity against any strain. Its comments came amid British govt's plan for its strictest Covid-19 restrictions as a highly infectious virus variant sweeps the country.

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said on Tuesday. moderna's vaccine will be the fourth Covid-19 jab to be available in India after Covishield, Covaxin and Sputnik.

The research, published in the Journal of the American Medical Association, also found those who received the moderna vaccine were less likely to be hospitalised, compared to recipients of the Pfizer-BioNTech vaccine.

President Donald Trump said Friday that the United States has authorized a second coronavirus vaccine, jumping the gun on regulators who have yet to give it the formal green light. "moderna vaccine overwhelmingly approved. Distribution to start immediately," he wrote on Twitter.

moderna Inc's vaccine against Covid-19 could be ready for use by the end of this year, company officials said on Monday, after the drugmaker announced the start of a 30,000-subject trial to demonstrate it is effective. The trial is the first such late-stage study under the Trump administration's program to speed development of measures against the coronavirus.